DRMA.jk: A bit more vroom — CFROA 8%, Market 6%
📅 July 1, 2025 – Based on March Cashflows
Cashflow return on assets (CFROA) rose to 8% from 6%, with cash retained during the quarter.
Market value equivalent is close at 6%, as the share price is up +5% year to date.
Leverage remains moderate, with net liabilities minus cash at 25% of assets.
🏎️ Data
• CFROA: 6% → 8%
• Market Value Equivalent: 6%
• Share Price: +5% YTD
• Leverage: 25%
• Rank: #75 in Top 100
⸻
For informational purposes only, not investment advice.
Upgrade to full SharpFokus access:
🔓 sharpfokus.com/subscribe – includes full CFROA data, daily reports, and morning meeting insights.
📅 July 1, 2025 – Based on March Cashflows
Cashflow return on assets (CFROA) rose to 8% from 6%, with cash retained during the quarter.
Market value equivalent is close at 6%, as the share price is up +5% year to date.
Leverage remains moderate, with net liabilities minus cash at 25% of assets.
🏎️ Data
• CFROA: 6% → 8%
• Market Value Equivalent: 6%
• Share Price: +5% YTD
• Leverage: 25%
• Rank: #75 in Top 100
⸻
For informational purposes only, not investment advice.
Upgrade to full SharpFokus access:
🔓 sharpfokus.com/subscribe – includes full CFROA data, daily reports, and morning meeting insights.